NRx Pharmaceuticals Inc (NRXPW) — Financial Flexibility Index
NRx Pharmaceuticals Inc (NRXPW) has a Financial Flexibility Index of -0.13x as of December 2025. Free cash flow of $-3.71 Million (operating CF $-3.71 Million minus capex $0.00) represents 0% of total liabilities ($28.89 Million). Also explore NRx Pharmaceuticals Inc (NRXPW) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NRx Pharmaceuticals Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for NRx Pharmaceuticals Inc across 9 annual periods. Check NRXPW cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for NRx Pharmaceuticals Inc (2017–2025)
Year-by-year free cash flow to debt coverage for NRx Pharmaceuticals Inc. For the full company profile including market capitalisation, see NRx Pharmaceuticals Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.49x | $-14.11 Million | $-14.11 Million | $28.89 Million | ▼ -23.4% |
| 2024 | -0.40x | $-10.64 Million | $-10.64 Million | $26.87 Million | ▲ +65.2% |
| 2023 | -1.14x | $-21.65 Million | $-21.66 Million | $19.05 Million | ▲ +47.4% |
| 2022 | -2.16x | $-39.74 Million | $-39.76 Million | $18.41 Million | ▲ +31.7% |
| 2021 | -3.16x | $-37.70 Million | $-37.70 Million | $11.92 Million | ▼ -6426.1% |
| 2020 | -0.05x | $-2.26 Million | $-2.27 Million | $46.71 Million | ▲ +84.3% |
| 2019 | -0.31x | $-792.73K | $-792.73K | $2.57 Million | ▲ +18.2% |
| 2018 | -0.38x | $-473.19K | $-473.19K | $1.26 Million | ▲ +74.2% |
| 2017 | -1.46x | $-135.81K | $-135.81K | $93.17K | — |